Role of Garbhasamskara on maternal wellbeing and baby growth

INTERVENTION: CONDITION: Health Condition 1: O20‐O29‐ Other maternal disorders predominantly related to pregnancy PRIMARY OUTCOME: Achievement of maternal wellbeing assessed through weight, abdominal circumference, haemoglobin, Blood pressure, proteinuria.Timepoint: Assessed at the baseline i.e, 20 weeks of gestational age and at 24th, 28th, 32nd weeks of gestational age SECONDARY OUTCOME: 1.Maintenance of optimum foetal growth assessed through measurements of biparietal diameter, head circumference, abdominal circumference and femur length. ; 2.Effect on maternal serum cortisol level measured at 9 am and perceived stress scale. ; 3.Rate of development of PIH,GDM and anaemia in pregnant women. ; 4.Rate of occurrence of IUGR in foetuss ; 5.Doppler velocimetry parameters including Umbilical, Uterine artery, MCA in reference to changes seen in PIH and IUGR.Timepoint: 1.Effect on maternal serum cortisol level and perceived stress scale. ; 2.Rate of development of PIH, GDM and anemia in pregnant women at the end of study. ; 3.Rate of occurrence of IUGR in foetus. Timepoint: Changes in Doppler velocimetry parameters Umbilical, Uterine artery, MCA in reference to changes seen in PIH and IUGR. INCLUSION CRITERIA: Married women with age group between 21 to 40 years with single viable pregnancy confirmed by USG. Single viable pregnancy between 18 to 20 weeks of gestational age both primary and multigravida will be included. Pregnant women with history of abortion or still birth or BOH or Preterm delivery will also be included. Pregnant women with history of PIH or GDM in previous pregnancy. Pregnant women having any one or more of the above said criteria will be included in the study.